China Pharma Holdings Inc (CPHI) — Cash Flow Reinvestment Rate

Latest as of June 2025: 0.07x

China Pharma Holdings Inc (CPHI) has a Cash Flow Reinvestment Rate of 0.07x as of June 2025, reinvesting $19.84K (capex $9.92K plus investments $-9.92K) from operating cash flow of $291.08K. See China Pharma Holdings Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.07x
(Capex + Investments) / Operating CF

Total Reinvested

$19.84K
Capex + Investments

Operating Cash Flow

$291.08K
USD

Capital Expenditures

$9.92K
USD

China Pharma Holdings Inc Cash Flow Reinvestment Rate (2007–2019)

Historical reinvestment intensity for China Pharma Holdings Inc across 13 annual periods. For the full cash flow conversion analysis, see China Pharma Holdings Inc cash flow conversion.

Annual Cash Flow Reinvestment Rate for China Pharma Holdings Inc (2007–2019)

Year-by-year capital reinvestment analysis for China Pharma Holdings Inc. See financial agility of China Pharma Holdings Inc to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2019 0.45x $272.01K $608.31K $136.00K ▲ +449.5%
2018 0.08x $102.29K $1.26 Million $51.15K ▼ -74.9%
2017 0.32x $272.96K $841.22K $136.48K ▲ +142.9%
2016 0.13x $386.81K $2.90 Million $193.40K ▼ -80.7%
2015 0.69x $2.32 Million $3.35 Million $2.32 Million ▼ -45.8%
2014 1.28x $5.84 Million $4.57 Million $5.84 Million ▼ -42.5%
2013 2.22x $19.09 Million $8.60 Million $19.09 Million ▲ +62.3%
2012 1.37x $4.99 Million $3.64 Million $4.99 Million ▲ +29.3%
2011 1.06x $5.54 Million $5.24 Million $5.54 Million ▼ -21.7%
2010 1.35x $10.52 Million $7.79 Million $10.52 Million ▼ -6.2%
2009 1.44x $15.36 Million $10.67 Million $15.36 Million ▲ +10.9%
2008 1.30x $8.49 Million $6.54 Million $8.49 Million ▲ +21.7%
2007 1.07x $2.99 Million $2.80 Million $2.99 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow